Butterfly Network (BFLY) Cash from Operations Growth (3y) (2023 - 2026)
Butterfly Network (BFLY) Cash from Operations Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.21 Bn | 176.92 Bn | 6.27 Bn | 4.78% |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn | 9.30% |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn | 1.51% |
| 4 | Boston Scientific | 68.62 Bn | 67.16 Bn | 3.61 Bn | 22.35% |
| 5 | Edwards Lifesciences | 47.39 Bn | 43.72 Bn | 1.29 Bn | -48.14% |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.16 Bn | 1.98 Bn | -14.75% |
| 7 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | 50.11% |
| 8 | Smith & Nephew | 27.03 Bn | 26.46 Bn | - | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.43 Bn | 2.07 Bn | 0.50% |
| 10 | Butterfly Network | 1.77 Bn | 1.63 Bn | 18.29 Mn | 31.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.51% |
| Dec 31, 2025 | 32.25% |
| Sep 30, 2025 | 59.05% |
| Jun 30, 2025 | 45.39% |
| Mar 31, 2025 | 40.06% |
| Dec 31, 2024 | 58.22% |
| Sep 30, 2024 | 44.56% |
| Jun 30, 2024 | 35.05% |
| Mar 31, 2024 | 31.19% |
| Dec 31, 2023 | 14.04% |
| Sep 30, 2023 | 9.65% |
| Jun 30, 2023 | -10.30% |
| Mar 31, 2023 | -30.04% |